U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07868068) titled 'Detection of Blood in the GI Lumen With HemoPill Acute' on Oct. 05.
Brief Summary: The goal of this clinical trial is to learn if the HemoPill acute (trial device) can detect the presence of blood in participants suspected of having upper gastrointestinal bleeding. The main question it aims to answer is:
-What is the clinical relationship between the HemoPill acute (trial device) and endoscopy (control procedure) in detecting the presence of blood/bleeding in the upper gastrointestinal tract?
Participants will:
* Swallow the HemoPill acute device one (1) to four (4) hours before their scheduled standard of care endoscopy procedur...